Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on spironolactone for the treatment of schizophrenia
DRKS00008750Phase 2Completed
- Sponsor
- LMU Klinikum
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of spironolactone in schizophrenia (3 arms), sponsored by LMU Klinikum. Started Jun 2015; status: completed.
02
Drugs
spironolactone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on DRKS00008750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00008750.